Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.82 |
| ▸ | MEN1 | O00255 | 2/20 | 0.82 |
| ▸ | CASR | P41180 | 1/20 | 0.51 |
| ▸ | BCL2 | P10415 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9906175 | 1.00 | KMT2A (0.82) | KMT2AMEN1CASRBCL2MAPK1 | |
| SCHEMBL4062666 | 1.00 | KMT2A (0.82) | KMT2AMEN1CASRBCL2MAPK1 | |
| SCHEMBL26402 | 0.91 | MEN1 (1.00) | KMT2AMEN1CASRBCL2MAPK1 | |
| SCHEMBL249404 | 0.85 | KMT2A (0.55) | KMT2AMEN1MAPK1TSHRHIF1A | |
| SCHEMBL11511851 | 0.83 | TSHR (0.61) | KMT2AMEN1BCL2MAPK1TSHR | |
| SCHEMBL2864477 | 0.83 | TSHR (0.61) | KMT2AMEN1BCL2MAPK1TSHR | |
| Ammonia Solution, Strong SCHEMBL11855911 | 0.83 | KMT2A (0.52) | KMT2AMEN1MAPK1TSHRHIF1A | |
| SCHEMBL11106824 | 0.82 | MEN1 (0.82) | KMT2AMEN1CASRMAPK1TSHR | |
| SCHEMBL28076978 | 0.82 | MEN1 (0.82) | KMT2AMEN1CASRBCL2MAPK1 | |
| SCHEMBL25039218 | 0.81 | KMT2A (0.52) | KMT2AMEN1BCL2MAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105732249-B | Aryl alcohol compound and escitalopram synthetic method | 中国科学院上海有机化学研究所 | 2019-03-15 | — | — | CN | disclosed |
| US-9434705-B2 | L-setastine hydrochloride and preparation method thereof | ANHUI QINGYUN PHARMACEUTICAL & CHEMICAL CO., LTD. (CN) | 2016-09-06 | — | — | US | disclosed |
| US-9434705-B2 | L-setastine hydrochloride and preparation method thereof | ANHUI QINGYUN PHARMACEUTICAL & CHEMICAL CO., LTD. (CN) | 2016-09-06 | — | — | US | disclosed |
| CN-105732249-A | Synthesis method of aryl alcohol compound and Escitalopram | 中国科学院上海有机化学研究所 | 2016-07-06 | — | — | CN | disclosed |
| US-20140296517-A1 | L-Setastine Hydrochloride and Preparation Method Thereof | ANHUI QINGYUN PHARMACEUTICAL | 2014-10-02 | — | — | US | disclosed |
| US-20140296517-A1 | L-Setastine Hydrochloride and Preparation Method Thereof | ANHUI QINGYUN PHARMACEUTICAL | 2014-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296517-A1 | L-Setastine Hydrochloride and Preparation Method Thereof | HRH4, HRH1, HRH3 | KMT2A 29/4885MEN1 1797/4885CASR 2810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.